Cargando…

Compatibility and Kidney Transplantation: The Way to Go

Long lasting debates in the past questioned the relevance of any sort of compatibility in post mortal kidney transplantation. It is for no say that fully compatible transplants have the highest chances for a long patient and graft survival. In the present report the use of HLA-DR as a representative...

Descripción completa

Detalles Bibliográficos
Autor principal: Doxiadis, Ilias I. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350869/
https://www.ncbi.nlm.nih.gov/pubmed/22593759
http://dx.doi.org/10.3389/fimmu.2012.00111
_version_ 1782232704259981312
author Doxiadis, Ilias I. N.
author_facet Doxiadis, Ilias I. N.
author_sort Doxiadis, Ilias I. N.
collection PubMed
description Long lasting debates in the past questioned the relevance of any sort of compatibility in post mortal kidney transplantation. It is for no say that fully compatible transplants have the highest chances for a long patient and graft survival. In the present report the use of HLA-DR as a representative of the Major Histocompatibility Complex class II genes in the allocation of organs is discussed. The major arguments are the easiness to offer to patients a compatible graft in a relatively short waiting time, an increase in graft survival, the less sensitization during the transplantation period, and the lower waiting time for a retransplant. Even if the number of organ donors remains the same a lowering of the mean waiting time is expected because of the longer period of graft survival.
format Online
Article
Text
id pubmed-3350869
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33508692012-05-16 Compatibility and Kidney Transplantation: The Way to Go Doxiadis, Ilias I. N. Front Immunol Immunology Long lasting debates in the past questioned the relevance of any sort of compatibility in post mortal kidney transplantation. It is for no say that fully compatible transplants have the highest chances for a long patient and graft survival. In the present report the use of HLA-DR as a representative of the Major Histocompatibility Complex class II genes in the allocation of organs is discussed. The major arguments are the easiness to offer to patients a compatible graft in a relatively short waiting time, an increase in graft survival, the less sensitization during the transplantation period, and the lower waiting time for a retransplant. Even if the number of organ donors remains the same a lowering of the mean waiting time is expected because of the longer period of graft survival. Frontiers Research Foundation 2012-05-14 /pmc/articles/PMC3350869/ /pubmed/22593759 http://dx.doi.org/10.3389/fimmu.2012.00111 Text en Copyright © 2012 Doxiadis. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
spellingShingle Immunology
Doxiadis, Ilias I. N.
Compatibility and Kidney Transplantation: The Way to Go
title Compatibility and Kidney Transplantation: The Way to Go
title_full Compatibility and Kidney Transplantation: The Way to Go
title_fullStr Compatibility and Kidney Transplantation: The Way to Go
title_full_unstemmed Compatibility and Kidney Transplantation: The Way to Go
title_short Compatibility and Kidney Transplantation: The Way to Go
title_sort compatibility and kidney transplantation: the way to go
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350869/
https://www.ncbi.nlm.nih.gov/pubmed/22593759
http://dx.doi.org/10.3389/fimmu.2012.00111
work_keys_str_mv AT doxiadisiliasin compatibilityandkidneytransplantationthewaytogo